OnKure Therapeutics, Inc.
OKUR
$2.60
-$0.02-0.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.46M | -60.31M | -59.06M | -52.67M | -44.69M |
| Total Depreciation and Amortization | 836.00K | 787.00K | 723.00K | 662.00K | 579.00K |
| Total Amortization of Deferred Charges | 14.00K | 141.00K | 142.00K | 142.00K | 128.00K |
| Total Other Non-Cash Items | 11.32M | 8.44M | 7.34M | 4.70M | 2.10M |
| Change in Net Operating Assets | -12.39M | -10.35M | -3.64M | -3.95M | 7.10M |
| Cash from Operations | -63.67M | -61.29M | -54.49M | -51.12M | -34.78M |
| Capital Expenditure | -52.00K | -64.00K | -61.00K | -52.00K | -70.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.93M | 15.93M | 15.93M | 15.93M | -- |
| Cash from Investing | 15.87M | 15.86M | 15.86M | 15.87M | -70.00K |
| Total Debt Issued | 0.00 | 0.00 | 6.00M | 6.00M | 6.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 58.88M | 58.89M | 58.90M | 58.91M | 34.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 51.29M | 51.29M | 51.15M | 51.22M | -141.00K |
| Cash from Financing | 110.17M | 110.17M | 116.04M | 116.13M | 5.89M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.37M | 64.74M | 77.41M | 80.89M | -28.96M |